Safe mutant viral vaccines

Details for Australian Patent Application No. 2004268514 (hide)

Owner Pfizer Products Inc.

Inventors Cao, Xuemei; Calvert, Jay Gregory; O'Hara, Michael K.; Welch, Siao-Kun Wan

Agent Shelston IP

Pub. Number AU-B-2004268514

PCT Pub. Number WO2005/021034

Priority 60/490,834 29.07.03 US

Filing date 26 July 2004

Wipo publication date 10 March 2005

Acceptance publication date 21 January 2010

International Classifications

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/295 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent viral antigens

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/021034 Priority application(s): WO2005/021034

24 April 2008 Assignment before Grant

  Welch, Siao-Kun Wan; Calvert, Jay Gregory; O'Hara, Michael K.; Cao, Xuemei The application has been assigned to Pfizer Products Inc.

21 January 2010 Application Accepted

  Published as AU-B-2004268514

20 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268516-Device and method for body lumen occlusion

2004268513-Monoclonal antibodies against ricin toxin and methods of making and using thereof